- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Stephen Wilcox
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Discoveries

Over the past 100 years, our discoveries have advanced scientific understanding and resulted in new and more effective treatments for patients.
From our early beginnings researchers at the Walter and Eliza Hall Institute have been making significant discoveries in immunity, cancer and infectious diseases.
“Scientific discoveries rarely occur through Eureka moments in one individual. More commonly, discoveries and the resulting improvements in human health are the result of creative, insightful, hard-working teams who devote decades to their research.”
- Professor Don Metcalf
Discoveries in immune disorders
Immune cell function
- The ‘clonal selection theory’ developed by Sir Frank Macfarlane Burnet proved that each antibody-producing cell is programmed to recognise just one infectious agent. When this match occurs, the cell will clone itself to fight the infection. The theory revolutionised our understanding of immunity.
- Discovering that cells from the thymus (T cells) help cells from the bone marrow (B cells) to generate antibodies. This demonstrated that immune cell collaboration and communication is central to immunity.
- Demonstration that dendritic cells can develop from diverse precursors.
- Identifying that proteins called histamines trigger severe allergic (anaphylactic) reactions.
Autoimmune and inflammatory diseases
- Proving the immune system learns to recognise and tolerate its own cells and tissues, so it can respond to foreign agents. This discovery of acquired immunological tolerance earned Burnet and Sir Peter Medawar the 1960 Nobel Prize.
- Proposing the radical theory that the immune system can go awry and attack the body’s own tissue, causing autoimmune diseases. Autoimmunity is now universally accepted as the cause of diseases such as type 1 diabetes, rheumatoid arthritis and Crohn’s disease.
- Identifying that the blood hormones G-CSF and GM-CSF promote inflammation in rheumatoid arthritis. Antibodies that block this action are in development.
Improving treatment for immune disorders
- Initiating medical treatment of autoimmunity with drugs that suppress the immune system, which is still the gold standard today.
- Development and clinical application of metabolic and immunological testing to identify people, particularly children, at risk of developing type 1 diabetes.
- Identifying the three peptides in gluten that are toxic for people with coeliac disease, which provides targets for a potential vaccine.
- Identifying a new and less invasive diagnostic test for coeliac disease, which is now in trials.
Discoveries in cancer
- Identifying CSFs (colony stimulating factors), the white blood cell signaling hormones that boost infection-fighting white blood cells in the body. The discovery has already helped more than 20 million cancer patients worldwide to recover from chemotherapy and revolutionised blood stem cell transplantation.
- Discovering that the protein BCL-2 prevents cells from dying when they should, thereby contributing to cancer development and thwarting cancer treatment. This finding has revolutionised understanding of cancers and autoimmune disorders. It has also led to the development of a new class of anti-cancer agents currently in clinical trials.
- Identifying breast stem cells and demonstrating that a single breast cell can generate a fully functional breast. This has already led to discovery of the cell of origin of BRCA1-related hereditary breast cancers, and explained the link between female hormones and increased risk of breast cancer. We are now trialling a new preventive drug to switch-off cancer causing cells.
Discoveries in infectious diseases
Viral infections
- Identifying that the poliomyelitis virus, which causes polio, enters the body via the mouth and infects the intestinal lining. This discovery led to improved public health strategies in the 1960s.
- Discovering influenza is an RNA virus and can exchange genetic material to create new virus strains. This knowledge has helped to explain how pandemic flu viruses emerge.
- Identifying that the viruses that attack bacterium (bacteriophages) hide by integrating and reproducing in the bacteria’s DNA. This discovery has subsequently become a major tool for genetic research.
Bacterial infections
-
Discovering the bacteria that cause Q fever, Coxiella burnetii, and psittacosis, Chlamydophila psittaci
Parasitic infections
- Discovering how T cells recognise parasite proteins, leading to identification of the first parasite-specific antibodies for detecting and diagnosing parasitic infections.
- Explaining how the malaria parasite Plasmodium falciparum evades detection by the immune system by varying the genetic code of proteins on the surface of malaria-infected cells.
- Discovering how Plasmodium falciparum parasites become resistant to certain antimalarial drugs. This has enabled monitoring of the spread of drug-resistant malaria and development of new anti-malarial treatments.
Vaccination
- Developing the current procedure for growing influenza virus in sufficient quantities to produce the flu vaccine.
- Pioneering a new approach to improve vaccine efficacy, by targeting antigens directly to dendritic cells. This is now a major field of research for making better vaccines for infectious diseases and cancers.